Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
POLEM试验的原理和设计:avelumab联合氟尿嘧啶类化疗作为III期错配修复缺陷或POLE外切酶结构域突变结肠癌的辅助治疗:一项III期随机研究
期刊:ESMO Open
影响因子:8.3
doi:10.1136/esmoopen-2019-000638
Lau, David; Kalaitzaki, Eleftheria; Church, David N; Pandha, Hardev; Tomlinson, Ian; Annels, Nicola; Gerlinger, Marco; Sclafani, Francesco; Smith, Gillian; Begum, Ruwaida; Crux, Richard; Gillbanks, Angela; Wordsworth, Sarah; Chau, Ian; Starling, Naureen; Cunningham, David; Dhillon, Tony